05:30 AM EST, 12/12/2024 (MT Newswires) -- NewAmsterdam Pharma ( NAMS ) said late Wednesday it has priced an underwritten public offering of 12.1 million shares at $24.50 per share and pre-funded warrants to purchase 4.9 million shares at $24.4999 per warrant.

The company said it has also granted underwriters a 30-day option to purchase up to 2.6 million additional shares

The company said it expects gross proceeds from the offering, anticipated to close on Thursday, of $416.5 million.